Skip to content
Brain & Nerves — Multiple sclerosis therapiesATC L04AG08

Ocrelizumab

Prescription only

Twice-yearly infusion for relapsing and primary progressive MS.

Starts working
Weeks to months
Half-life
About 26 days
In use since
—
Pregnancy
Usually avoided

Overview

Ocrelizumab depletes B cells and is the first treatment approved for primary progressive MS. It is given as an infusion twice a year and increases infection risk.

Conditions it's used for

How it works

Removes immune B cells that drive MS damage.

Ocrelizumab belongs to the Multiple sclerosis therapies. How Multiple sclerosis therapies work: calm or redirect the immune system so it attacks the nerve coating less.

Uses

  • Relapsing MS
  • Primary progressive MS

Available as: iv infusion every 6 months, subcutaneous injection (some regions).

Typical dose

Adults
300 mg IV twice two weeks apart, then 600 mg every 6 months.

Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.

Side effects

Common

Often mild and may settle with time

  • Infusion reactions
  • Respiratory infections
  • Herpes infections

Serious — get medical help

Uncommon, but need prompt attention

  • Serious infections
  • Hepatitis B reactivation
  • Possible increase in breast cancer
  • PML (rare)

Warnings

  • Hepatitis B screening before starting
  • Pre-medication reduces infusion reactions

Who should avoid it

  • Active hepatitis B
  • Active serious infection

Interactions

  • Other immunosuppressants — added infection risk
  • Live vaccines — avoid
Check Ocrelizumab against your own medicines

Using it safely

Alcohol
Usually no problem in moderation. No known interaction.
Food and drink
Not applicable.
If you miss a dose
Contact the infusion centre.
Stopping it
Stop only on specialist advice.
Driving
Infusion reactions may affect alertness the same day.
Tests and checks
Hepatitis B status; Immunoglobulin levels; Infections
If too much is taken
Seek advice.
Storage
Refrigerate.
Legal status
United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule HAustralia: Prescription only (Schedule 4)

Pregnancy and breastfeeding

Pregnancy

Usually avoided

Avoid unless needed; contraception advised.

Breastfeeding

Use with caution

Large antibody; limited data.

Special groups

Kidney disease
No adjustment.
Liver disease
Use caution.
Older adults
Limited data.

Brand names

United States
Ocrevus
United Kingdom
Ocrevus
India
Ocrevus
Australia
Ocrevus

Examples only; many generic versions exist. The same brand name can mean different products in different countries.

Common questions

Do I need a prescription for Ocrelizumab?

Yes — Ocrelizumab is prescription-only in most countries.

Can I take Ocrelizumab during pregnancy?

Usually avoided. Avoid unless needed; contraception advised. Always check with a doctor or midwife.

How quickly does Ocrelizumab work?

Weeks to months.

Sources and official information

Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.